iRadimed Corp. (IRMD) Shares Down 5.7%
Shares of iRadimed Corp. (NASDAQ:IRMD) fell 5.7% during mid-day trading on Thursday . The stock traded as low as $17.50 and last traded at $17.61, with a volume of 85,282 shares trading hands. The stock had previously closed at $18.67.
Separately, Zacks Investment Research downgraded iRadimed Corp. from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 5th.
The stock’s 50 day moving average is $18.46 and its 200 day moving average is $18.34. The firm has a market cap of $187.93 million and a P/E ratio of 25.30.
iRadimed Corp. (NASDAQ:IRMD) last announced its quarterly earnings data on Friday, July 29th. The company reported $0.24 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.03. The firm earned $9.90 million during the quarter, compared to analyst estimates of $9.60 million. During the same period in the prior year, the company posted $0.16 earnings per share. The firm’s revenue for the quarter was up 30.3% on a year-over-year basis. On average, analysts forecast that iRadimed Corp. will post $0.92 earnings per share for the current fiscal year.
In other news, Director Monty K. Allen sold 2,100 shares of the stock in a transaction dated Monday, June 13th. The stock was sold at an average price of $20.44, for a total value of $42,924.00. Following the transaction, the director now directly owns 4,375 shares of the company’s stock, valued at $89,425. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Monty K. Allen sold 2,275 shares of the stock in a transaction dated Tuesday, June 14th. The shares were sold at an average price of $20.00, for a total value of $45,500.00. The disclosure for this sale can be found here.
IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.